ClinicalTrials.gov
ClinicalTrials.gov Menu

Study Safety and Preliminary Efficacy of DCC-2036 in Patients With Leukemias (Ph+ CML With T315I Mutation)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00827138
Recruitment Status : Completed
First Posted : January 22, 2009
Last Update Posted : July 18, 2014
Sponsor:
Information provided by (Responsible Party):
Deciphera Pharmaceuticals LLC